Mid-Term Outcomes of Minimally Invasive Direct Coronary Artery Bypass Grafting.

Conclusion MIDCAB is a safe procedure with low postoperative morbidity, mortality, and favorable mid-term MACCE-free survival in selected patients that should be discussed in a heart team setting to evaluate the "ideal" individual treatment option.
PMID: 25207487 [PubMed - as supplied by publisher]

Source: The Thoracic and Cardiovascular Surgeon - September 10, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Reser D, Hemelrijck MV, Pavicevic J, Tolboom H, Holubec T, Falk V, Jacobs S Tags: Thorac Cardiovasc Surg Source Type: research